Orapharma, Inc.
Records under this name other than the patents Orapharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 6 of 6 · Back to Orapharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,799,824 | Quaternary Salt CCR2 Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 6,682,348 | Dispensing Apparatus and Cartridge Term ended Term ended Mar 29, 2022 · High confidence | Term ended | Term ended Mar 29, 2022 | High confidence |
| US 7,699,609 | Dispensing Apparatus and Cartridge with Deformable Tip Term ended Term ended Mar 29, 2022 · High confidence | Term ended | Term ended Mar 29, 2022 | High confidence |
| US 6,946,118 | Formulations for treating or preventing mucositis Formerly held Lapsed on the fee record Ended Sep 20, 2013 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2013 | From the USPTO record |
| US 6,893,665 | Formulations for Treating or Preventing Mucositis Formerly held Lapsed on the fee record Ended May 17, 2013 · Medium confidence | Lapsed on the fee record | Ended May 17, 2013 | Medium confidence |
| US 6,683,067 | Formulations for Treating or Preventing Mucositis Formerly held Lapsed on the fee record Ended Jan 27, 2012 · Medium confidence | Lapsed on the fee record | Ended Jan 27, 2012 | Medium confidence |